MedisensonicS.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2023-02-09
Share capital
694 963,50 PLN
Activity description

Medisensonic is a MedTech and DefTech company that develops non-invasive medical devices using military microwave technology, including the Glucowave for continuous glycemic monitoring and the MPVT for measuring pulp vitality in dentistry. It also offers solutions for UAV detection and disposal, enhancing border defense and protecting critical infrastructure. The company operates in key medical fields such as cardiology, diabetology, dentistry, and oncology.

Registered address
ul. Edmunda Kajdasza 4A/3, 52-234 Wrocław, Poland
Website
medisensonic.comWebsite active
Social media
Electronic delivery address
AE:PL-88377-96878-JHTTU-32

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 362.57kMedianUSD 72.15kAverageUSD 3.22m
Net profit
This companyUSD -2.08mMedianUSD 87.69AverageUSD 112.20k
Operating costs
This companyUSD 1.58mMedianUSD 75.02kAverageUSD 3.02m
Assets
This companyUSD 247.50kMedianUSD 121.49kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2018-05-14. Active

  • mBank
    20 1140 1010 0000 4413 4700 1005
  • mBank
    31 1140 1010 0000 4413 4700 1001
  • mBank
    36 1140 1010 0000 4413 4700 1008

Debt

1 active proceeding recorded in KRZ. Active proceeding

Registration dateProceeding typeStatus
Jan 7, 2026
Petition to declare entrepreneur bankruptcy
In progress

Public aid

17 public aid cases recorded, with a total value of $6,105,819.

Grant datePurposeGross amountGranting body
Mar 18, 2026
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,459Prezes Zakładu Ubezpieczeń Społecznych
Sep 17, 2025
De minimis aid (in accordance with Commission Regulation 2023/2831)
$2,073Prezes Zakładu Ubezpieczeń Społecznych
Jul 31, 2025
De minimis aid (in accordance with Commission Regulation 2023/2831)
$6,251Prezes Zakładu Ubezpieczeń Społecznych

European Funds

StartProjectEU co-financingProgramme
2021-01-01
Opracowanie prototypu systemu do bezinwazyjnego monitorowania poziomu glikemii u człowieka (Glucowave)
$2,153,403Program Operacyjny Inteligentny Rozwój
2019-03-01
Prace badawczo-rozwojowe nad nowym urządzaniem do diagnostyki stanu miazgi zęba oparte na technologii mikrofal (Microwave Pulp Vitality Tester – MPVT)
$1,331,088Program Operacyjny Inteligentny Rozwój

Tenders

1 tender recorded as contractor, with a total value of $6,874.

Publication dateSubjectAmountContracting authority
Sep 7, 2021
Usługa polegająca na przygotowaniu prototypu rozwiaązania zbierajaącego wynik z sygnału mikrofalowego
$6,874Olsztyński Park Naukowo-Technologiczny

Authorized Representatives

Paweł Bala — President of the Management Board
Robert Gromada — President of the Management Board
Zenon Rafał Szczepaniak — Attorney-in-fact (sole)

Manner of representation

The company is represented as follows: a) in the case of a one-person management board, the President of the Management Board is authorised to make declarations of will on behalf of the company independently; b) in the case of a multi-member management board, the President of the Management Board is authorised to make declarations of will on behalf of the company independently, or two members of the management board jointly, or one member of the management board jointly with a commercial proxy.

Supervisory board

Jakub Szymon Karbowiak — Supervisory Board Member
Michał Komorowski — Supervisory Board Member
Sławomir Łukasz Kościak — Supervisory Board Member
Szymon Kuliński — Supervisory Board Member
Michał Suflida — Supervisory Board Member

Beneficial owners

PersonRights
Paweł Bala (54)
Shareholder of a joint-stock company, 33.1%

Subsidiaries

NameShare valueStake
Deventivsp. z o.o.
10,804.97 USD100%
5,402.49 USD100%

Competitors

NameRevenueWebsite
Saventic Healthsp. z o.o.$1,089,246.05saventic.com
Bulletprovesp. z o.o.$867,545.53bulletprove.com
MTCS.A.$825,216.26mtcenter.pl
OrthogetS.A.$532,980.53orthoget.com
VET Cell Techsp. z o.o.$483,439.81vetcelltech.com
DigitmedS.A.$382,907.91digitmed.pl
Green ZebrasS.A.$328,658.91whygreenzebras.pl
BiocamS.A.$327,799.68biocam.ai
Medicofarma BiotechS.A.$314,882.33medicofarmabiotech.pl
Digital Engineering Solutionssp. z o.o.$101,178.20de-solutions.info

Change history

DateEvent
2026-05-26Share capital change (231,654.50 PLN → 694,963.50 PLN)
2026-01-30Share capital change (218,204.10 PLN → 231,654.50 PLN)
2025-06-11Address change (Ul. Szczytnicka 11, 50-382, Wrocław → Ul. Edmunda Kajdasza 4a/3, 52-234, Wrocław)
2025-03-17Share capital change (214,174.60 PLN → 218,204.10 PLN)
2024-10-04Share capital change (209,300.00 PLN → 214,174.60 PLN)

FAQ

Last updated: 2026-07-30